Beyond second-line therapy in patients with metastatic colorectal cancer: a systematic review

Por Arnold, D, Prager, G W, Quintela, A, Stein, A, Moreno Vera, S, Mounedji, N, Taieb, J
Publicado no Ann Oncol (2018)

PD-026 Survival outcomes in patients with RAS wild-type (WT) metastatic colorectal cancer (mCRC) classified by Köhne prognostic category and BRAF mutation status: retrospective ana...

Por Köhne, C.-H., Rivera, F., Taieb, J., Siena, S., Peeters, M., Koukakis, R., Demonty, G., Douillard, J.-Y.
Publicado no Ann Oncol (2016)

PD-028 Retrospective analysis of impact of Köhne prognostic category and BRAF mutation status on survival in patients with RAS wild-type metastatic colorectal cancer treated with s...

Por Peeters, M., Siena, S., Douillard, J.-Y., Rivera, F., Taieb, J., Koukakis, R., Demonty, G., Köhne, C.-H.
Publicado no Ann Oncol (2016)

Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II–III colorectal cancer

Por Chaput, N, Svrcek, M, Aupérin, A, Locher, C, Drusch, F, Malka, D, Taïeb, J, Goéré, D, Ducreux, M, Boige, V
Publicado em 2013

Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study

Por Aparicio, T, Svrcek, M, Zaanan, A, Beohou, E, Laforest, A, Afchain, P, Mitry, Emmanuel, Taieb, J, Di Fiore, F, Gornet, J-M, Thirot-Bidault, A, Sobhani, I, Malka, D, Lecomte, T, Locher, C, Bonnetain, F, Laurent-Puig, P
Publicado em 2013

Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial

Por Samalin, E, Bouché, O, Thézenas, S, Francois, E, Adenis, A, Bennouna, J, Taieb, J, Desseigne, F, Seitz, J F, Conroy, T, Galais, M P, Assenat, E, Crapez, E, Poujol, S, Bibeau, F, Boissière, F, Laurent-Puig, P, Ychou, M, Mazard, T
Publicado em 2014

Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial—PRODIGE 20 study results

Por Aparicio, T, Bouché, O, Taieb, J, Maillard, E, Kirscher, S, Etienne, P -L, Faroux, R, Khemissa Akouz, F, El Hajbi, F, Locher, C, Rinaldi, Y, Lecomte, T, Lavau-Denes, S, Baconnier, M, Oden-Gangloff, A, Genet, D, Paillaud, E, Retornaz, F, François, E, Bedenne, L
Publicado no Ann Oncol (2018)

Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial—PRODIGE 20 study results

Por Aparicio, T, Bouché, O, Taieb, J, Maillard, E, Kirscher, S, Etienne, P -L, Faroux, R, Khemissa Akouz, F, El Hajbi, F, Locher, C, Rinaldi, Y, Lecomte, T, Lavau-Denes, S, Baconnier, M, Oden-Gangloff, A, Genet, D, Paillaud, E, Retornaz, F, François, E, Bedenne, L
Publicado no Ann Oncol (2018)

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

Por Grothey, A., Sobrero, A.F., Shields, A.F., Yoshino, T., Paul, J., Taieb, J., Souglakos, J., Shi, Q., Kerr, R., Labianca, R., Meyerhardt, J.A., Vernerey, D., Yamanaka, T., Boukovinas, I., Meyers, J.P., Renfro, L.A., Niedzwiecki, D., Watanabe, T., Torri, V., Saunders, M., Sargent, D.J., Andre, T., Iveson, T.
Publicado no N Engl J Med (2018)

Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: p...

Por Bang, Y -J, Ruiz, E Yañez, Van Cutsem, E, Lee, K -W, Wyrwicz, L, Schenker, M, Alsina, M, Ryu, M -H, Chung, H -C, Evesque, L, Al-Batran, S -E, Park, S H, Lichinitser, M, Boku, N, Moehler, M H, Hong, J, Xiong, H, Hallwachs, R, Conti, I, Taieb, J
Publicado no Ann Oncol (2018)

Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE—...

Por Yoshino, T, Portnoy, D C, Obermannová, R, Bodoky, G, Prausová, J, Garcia-Carbonero, R, Ciuleanu, T, García-Alfonso, P, Cohn, A L, Van Cutsem, E, Yamazaki, K, Lonardi, S, Muro, K, Kim, T W, Yamaguchi, K, Grothey, A, O’Connor, J, Taieb, J, Wijayawardana, S R, Hozak, R R, Nasroulah, F, Tabernero, J
Publicado no Ann Oncol (2019)

European survey on efficacy and safety of duty-cycled radiofrequency ablation for atrial fibrillation

Por Scharf, C., Ng, G.A., Wieczorek, M., Deneke, T., Furniss, S.S., Murray, St., Debruyne, Ph., Hobson, N., Berntsen, R.F., Schneider, M.A., Hauer, H.A., Halimi, F., Boveda, S., Asbach, S., Boesche, L., Zimmermann, M., Brigadeau, F., Taieb, J., Merkel, M., Pfyffer, M., Brunner-La Rocca, H.P., Boersma, L.V.A.
Publicado em 2012

Colorectal cancer (CRC) monitoring by 6-monthly (18)FDG-PET/CT: an open-label multicentre randomised trial

Por Sobhani, I, Itti, E, Luciani, A, Baumgaertner, I, Layese, R, André, T, Ducreux, M, Gornet, J -M, Goujon, G, Aparicio, T, Taieb, J, Bachet, J -B, Hemery, F, Retbi, A, Mons, M, Flicoteaux, R, Rhein, B, Baron, S, Cherrak, I, Rufat, P, Le Corvoisier, P, de’Angelis, N, Natella, P -A, Maoulida, H, Tournigand, C, Durand Zaleski, I, Bastuji-Garin, S
Publicado no Ann Oncol (2018)